SYMVESS is a first-in-class bioengineered human tissue designed to be a universally implantable vascular conduit for ... efficacy and safety of Humacyte's acellular tissue engineered vessel ...

Johns Hopkins Medicine is a leader in diagnosing, researching, and treating vascular anomalies. Our team of specialists treat patients of all ages, from newborns to adults. Vascular anomalies describe ...

Microvascular endothelial cells are thought to be the major targets of hyperglycemic injury. In diabetic microvasculature, the intracellular hyperglycemia causes damages to the vascular endothelium, ...

Likewise, we show that DC-SIGN expression is accentuated in M(IL-4) macrophages derived from peripheral blood CD14 + monocytes isolated from TB patients, or in macrophages stimulated with acellular TB ...